These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9523002)

  • 1. Does cyclophosphamide combined with methylprednisolone affect the expression of leukocyte function associated antigen 1 in refractory rheumatoid arthritis.
    Lacki JK; Müller-Ruchholtz W; Mackiewicz SH
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):285-8. PubMed ID: 9523002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis: the effect on lymphocytes.
    Lacki JK; Leszczynski P; Mackiewicz SH
    J Investig Allergol Clin Immunol; 1996; 6(4):232-6. PubMed ID: 8844499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA
    Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in clinical and laboratory findings on oxidation metabolism in lymphocyte membranes of rheumatoid arthritis patients on synchronous programmed intensive therapy].
    Lushpaeva IuA; Medvedeva IV; Fadienko GR
    Klin Med (Mosk); 2002; 80(5):39-42. PubMed ID: 12087885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leukocyte expression of the LFA-1 adhesion molecule in spondylarthropathies].
    Wendling D; Racadot E; Viel JF
    Rev Rhum Ed Fr; 1994 Jan; 61(1):23-8. PubMed ID: 8000397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
    Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT
    J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effect of oral and intravenous cyclophosphamide treatment on phenotypes of human peripheral blood lymphocytes.
    Lacki JK; Mackiewicz SH; Wiktorowicz KE
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):291-4. PubMed ID: 7487369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracorporeal therapy of rheumatoid arthritis].
    Aseeva EA; Solov'ev SK; Chiklikchi AS
    Ter Arkh; 2001; 73(6):70-5. PubMed ID: 11521529
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide therapy for rheumatoid arthritis.
    Smyth CJ; Bartholomew BA; Mills DM; Steigerwald JC; Strong SJ; Recart S
    Arch Intern Med; 1975 Jun; 135(6):789-93. PubMed ID: 1093503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
    Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The comparison of the effectiveness of treatment of multiple sclerosis relapse with high doses of methylprednisolone, alpha-24 corticotropin and cyclophosphamide].
    Paradowski B; Gruszka E; Pokryszko A
    Pol Merkur Lekarski; 1999 Jun; 6(36):305-7. PubMed ID: 10481540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Gastrin concentration in patients with rheumatoid arthritis: effect of long-term immunosuppressive or antidopaminergic treatment.
    Caldara R; Grimaldi MG; Barbieri C; Ferrari C
    Horm Metab Res; 1981 Nov; 13(11):615-7. PubMed ID: 7308971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide.
    Settles B; Stevenson A; Wilson K; Mack C; Ezell T; Davis MF; Taylor LD
    Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1105-14. PubMed ID: 11838958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of patients with rheumatoid arthritis treated with immunosuppressive agents between 1965 and 1973].
    Renier JC; Bregeon C; Bonnette C; Boasson M; Bernat M; Basle M; Besson J; Wellinger C; Bourgeois B; Teisseire N
    Rev Rhum Mal Osteoartic; 1978; 45(7-9):453-61. PubMed ID: 725461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone.
    Stack J; McLaughlin P; Sinnot C; Henry M; MacEneaney P; Eltahir A; Harney S
    Scand J Rheumatol; 2010 Aug; 39(4):349-50. PubMed ID: 20476869
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis.
    Breban M; Dougados M; Picard F; Zompi S; Marolleau JP; Bocaccio C; Heshmati F; Mezieres M; Dreyfus F; Bouscary D
    Arthritis Rheum; 1999 Nov; 42(11):2275-80. PubMed ID: 10555020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.